KEYSTONE SYMPOSIA ON MOLECULAR AND CELLULAR BIOLOGY
160 US HWY 6 STE 200, SILVERTHORNE, CO, 80498
Sweeping public federal award data (USAspending.gov) and refinancing rate arbitrage matrices for this entity.
Maturing high-rate specialty debt held by XEROX (Tier 3 Specialty Capital) at an estimated 24.5% APR can be consolidated to a Tier 1 Bank line at 8.5% APR.
Scan active SaaS tools, cloud infrastructure providers (AWS/GCP), CRM systems, and IT software expenditure for KEYSTONE SYMPOSIA ON MOLECULAR AND CELLULAR BIOLOGY on our technographic spy platform.
SCAN TECH STACK ON TECHNOGRAPHIC SPY →Generate automated AI cold email sequences, executive contact outreach, and B2B sales pipeline campaigns for KEYSTONE SYMPOSIA ON MOLECULAR AND CELLULAR BIOLOGY on our autonomous sales agent platform.
LAUNCH AUTONOMOUS OUTREACH ON SALESAGENTIC →Three commercial trigger event possibilities available for this company directory listing based on active Uniform Commercial Code filing records.
Analysis of state registrations ranked by chronological priority. Secondary creditors operate at subordinate stack position (N+1).
| Lien Position | Secured Creditor | Filing ID | Filing Date |
|---|---|---|---|
| 1 (Active) | CIT TECHNOLOGY | 702544 | 2009-07-22 |
| 2 (Active) | KONICA MINOLTA | 801528 | 2011-04-07 |
| 3 (Active) | KONICA MINOLTA | 1205365 | 2015-04-20 |
| 4 (Active) | XEROX | 1555852 | 2018-05-08 |
| 5 (Active) | XEROX | 2078046 | 2022-07-11 |
| 6 (Active) | XEROX | 2340924 | 2024-09-19 |
| 7 (Prospect) | Open Subordinate Refinancing Opportunity - Prospective Subordinated Position | ||